Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
AARTIIND.NSthis companyAarti Industries Limited	₹459.80	34.52×	2.43×	1.75×	15.99×	-240.0%	24.6%	8.2%	5.1%	7.0%	6.1%	-3.9%	0.83×	3.72×	1.99×	0.83×	0.2%	5	2.06	2	B-
AAREYDRUGS.NSAarey Drugs & Pharmaceuticals Limited	₹109.04	36.51×	0.96×	0.31×	14.58×	-99.9%	3.0%	0.9%	0.8%	2.6%	1.6%	-16.1%	0.33×	3.66×	0.86×	1.81×	0.0%	6	—	2	C
AARTIDRUGS.NSAarti Drugs Limited	₹499.75	14.97×	1.88×	1.14×	11.19×	-76.9%	29.2%	9.4%	7.6%	12.6%	10.1%	1.7%	0.37×	1.82×	7.19×	1.59×	0.6%	4	3.46	2	C
AARTIPHARM.NSAarti Pharmalabs Limited	₹921.40	32.96×	2.71×	3.16×	16.93×	-152.7%	54.1%	16.4%	9.6%	8.2%	7.3%	-3.2%	0.36×	1.94×	6.36×	1.49×	0.6%	6	4.24	3	B-
ACUTAAS.NSAcutaas Chemicals Limited	₹3,882.60	58.8×	12.67×	15.64×	43.22×	-132.9%	46.3%	33.2%	26.6%	21.5%	18.4%	-0.1%	0.02×	-0.39×	135.98×	3.82×	0.1%	7	64.58	3	B
AETHER.NSAether Industries Limited	₹1,590.10	66.13×	5.91×	12.51×	39.85×	-418.7%	37.1%	25.6%	18.9%	8.9%	7.5%	-3.4%	0.19×	1.2×	16.43×	1.78×	0.0%	3	12.88	3	B-
Peer median	—	36.51×	2.71×	3.16×	16.93×	-132.9%	37.1%	16.4%	9.6%	8.9%	7.5%	-3.2%	0.33×	1.82×	7.19×	1.78×	0.1%	6	8.56	3	—